Norway· NO-ID_0594FBEC-C10E-443D-B689-F276F9F6E1BF
Taflotan
A tafluprost product containing tafluprost, registered in Norway by Santen Oy. The same ATC class is registered in 16 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Tafluprost is registered in 16 of 19 countries.
Countries holding a registration under ATC S01EE05 (tafluprost), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Tafluprost · ATC S01EE05
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Tafluprost
- Manufacturer
- Santen Oy
- Country
- Norway (NO)
- ATC code
- S01EE05
- ATC class
- Tafluprost
- Defined daily dose
- 0.1 ml, AT
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 5
2 priced- no_varenummer13437490 x 0.3NOK 620.5
- gtin6419716000725
- no_merkevare_idID_0594FBEC-C10E-443D-B689-F276F9F6E1BF
- no_varenummer13435230 x 0.3NOK 231
- gtin6419716000671
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tafluprost in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatestafluprostMicro Labs Limited
- CzechiaTAFLOTANSanten OY, Tampere
- FinlandTaflotanOrifarm Oy
- NetherlandsSaflutan 15 microgram/ml oogdruppels, oplossingSanten Oy
- BelgiumSaflutan 15 µg/mlSanten
- SwedenTaflotan 15 mikrogram/ml Ögondroppar, lösning i endosbehållareSanten Oy
- PolandTaflotanSanten Oy
- IrelandSaflutan 15 micrograms/ml, eye drops, solution in single-dose containerPCO Manufacturing Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Saflutan
- Belgium · Saflutan
- Bulgaria · Taflotan, Тафлотан
- Cyprus · Saflutan, Taflotan
- Czechia · Taflotan
- Germany · Taflotan, Taflotan Sine
- Denmark · Taflotan, Taflotan Sine
- Estonia · Tafdera, Taflotan
- Spain · Saflutan, Taflotan
- Finland · Taflotan, Taflotan Sine
- France · Saflutan, Tafluprost Rph Pharmaceuticals
- United Kingdom (Northern Ireland) · Saflutan, Tafluprost Brown & Burk Uk
- Greece · Saflutan, Taflotan
- Croatia · Saflutan
- Hungary · Taflotan
- Ireland · Saflutan
- Iceland · Taflotan, Taflotan Sine
- Italy · Safluround, Saflutan
- Lithuania · Taflotan
- Luxembourg · Saflutan, Tafluprost Micro Labs
- Latvia · Taflotan
- Malta · Saflutan
- Netherlands · Saflutan
- Poland · Taflotan, Taflotan Multi
- Portugal · Saflutan, Taflotan
- Romania · Saflutan
- Sweden · Taflotan, Taflotan Sine
- Slovenia · Saflutan
- Slovakia · Taflotan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/303a19ae-b41f-4583-9f56-beb8cb8c9108 GET /v1/drugs/303a19ae-b41f-4583-9f56-beb8cb8c9108?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Øyedråper, oppløsning i endosebeholder",
"source": "fest",
"status": "A",
"atc_name": "Tafluprost",
"merkevare_id": "ID_0594FBEC-C10E-443D-B689-F276F9F6E1BF",
"name_form_strength": "Taflotan øyedr, oppl 15 mikrog/ml",
"prescription_group": "C"
}See everything about tafluprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.